These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35173950)

  • 1. Factors that influence the intention to use mobile phone caller tunes for patient reporting of adverse drug reactions: a qualitative study.
    Appiah B; Poudyal A; Burdine JN; Asamoah-Akuoko L; Anum DA; Kretchy IA; Sabblah G; Dodoo ANO; McKyer ELJ
    Ther Adv Drug Saf; 2019; 10():2042098619871190. PubMed ID: 35173950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of Intention to Use Mobile Phone Caller Tunes to Promote Voluntary Blood Donation: Cross-Sectional Study.
    Appiah B; Burdine JN; Aftab A; Asamoah-Akuoko L; Anum DA; Kretchy IA; Samman EW; Appiah PB; Bates I
    JMIR Mhealth Uhealth; 2018 May; 6(5):e117. PubMed ID: 29728343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions of a mobile phone-based approach to promote medication adherence: A cross-sectional application of the technology acceptance model.
    Appiah B; Kretchy IA; Yoshikawa A; Asamoah-Akuoko L; France CR
    Explor Res Clin Soc Pharm; 2021 Mar; 1():100005. PubMed ID: 35479503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists and COVID-19 vaccination - Considering mobile phone caller tunes as a novel approach to promote vaccine uptake in low- and middle-income countries.
    Appiah B; Asamoah-Akuoko L; France C; Rene A; Amanquah N; Bates I
    Res Social Adm Pharm; 2022 May; 18(5):2898-2903. PubMed ID: 34362688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report.
    Hariraj V; Aziz Z
    Ther Innov Regul Sci; 2018 Nov; 52(6):757-763. PubMed ID: 29714567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare professionals' willingness to utilize a mobile health application for adverse drug reaction reporting in a limited resource setting: An input for digital health, 2023.
    Dubale AT; Tareke AA; Butta FW; Shibabaw AA; Eniyew EB; Ahmed MH; Kassie SY; Demsash AW; Chereka AA; Dube GN; Walle AD; Kitil GW
    Eur J Obstet Gynecol Reprod Biol X; 2024 Sep; 23():100324. PubMed ID: 39050924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative Study of General Public Views towards Adverse Drug Reactions in Lithuania.
    Valinciute-Jankauskiene A; Loreta K
    Healthcare (Basel); 2021 Mar; 9(3):. PubMed ID: 33803215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Texting-Based Reporting of Adverse Drug Reactions to Ensure Patient Safety: A Feasibility Study.
    Vergeire-Dalmacion G; Castillo-Carandang NT; Juban NR; Amarillo ML; Tagle MP; Baja ES
    JMIR Public Health Surveill; 2015; 1(2):e12. PubMed ID: 27227130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.
    Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E
    Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Important information regarding reporting of adverse drug reactions: a qualitative study.
    Rolfes L; Wilkes S; van Hunsel F; van Puijenbroek E; van Grootheest K
    Int J Pharm Pract; 2014 Jun; 22(3):231-3. PubMed ID: 23937120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional study: comparison of public perceptions of adverse drug reaction reporting and monitoring in eastern and western China.
    Wang N; Chen Y; Ren B; Xiang Y; Zhao N; Zhan X; Feng B
    BMC Health Serv Res; 2022 Mar; 22(1):318. PubMed ID: 35260158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study.
    de Vries ST; Wong L; Sutcliffe A; Houÿez F; Ruiz CL; Mol PG;
    Drug Saf; 2017 May; 40(5):443-455. PubMed ID: 28035492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare personnel's experience of reporting adverse drug reactions in Baghdad city: cross-sectional study.
    Hussain SA; Abbas AN; Habeeb SA; Abd-Ali AK; Abdulrahman ZS
    Int J Clin Pharm; 2019 Oct; 41(5):1307-1313. PubMed ID: 31240554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First results from the lessons learnt from the deployment of the Med Safety App for reporting adverse drug reactions in Ghana.
    Seaneke SK; Darko DM; Nkansah E; Asamoa-Amoakohene A; Ashie A; Sampson Ewudzie J; Tregunno P; Raguenaud ME; Merle CS; Hennig BJ; Sabblah GT
    Digit Health; 2023; 9():20552076231211276. PubMed ID: 37936957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing patient intention to report adverse drug reaction to community pharmacists: A structural equation modeling approach.
    Assanee J; Sorofman BA; Sirisinsuk Y; Kitisopee T
    Res Social Adm Pharm; 2022 Apr; 18(4):2643-2650. PubMed ID: 34039528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting patient reporting of adverse drug reactions: a systematic review.
    Al Dweik R; Stacey D; Kohen D; Yaya S
    Br J Clin Pharmacol; 2017 Apr; 83(4):875-883. PubMed ID: 27868226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Have we missed reporting adverse drug reactions under Revised National TB Control Programme?' - A mixed method study in Bengaluru, India.
    Krishnappa L; Gadicherla S; Chidambaram P; Anuradha HV; Somanna SN; Naik PR; Das A; Narasimhaiah S; Nagaraja SB
    Indian J Tuberc; 2020 Jan; 67(1):20-28. PubMed ID: 32192612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.